Interferon-α Nasal Spray Safely Lowers COVID-19 Risk in Patients With Cancer - Oncology Nurse Advisor Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

IFN-α nasal spray reduces the incidence of #COVID19 infection by approximately 40% in patients with #cancer without increasing adverse events compared with placebo. Published in @infectiousdisease.bsky.social.

https://bit.ly/4nGjDf1

#COVID19nCancer

Interferon-α Nasal Spray Safely Lowers COVID-19 Risk in Patients With Cancer Interferon-α nasal spray was safe and effective for the prevention of COVID-19 among patients with cancer.

IFN-α nasal spray reduces the incidence of #COVID19 infection by approximately 40% in patients with #cancer without increasing adverse events compared with placebo. Published in @infectiousdisease.bsky.social.

https://bit.ly/4mKcOYA

#COVID19nCancer

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2...

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen ow.ly/qvGM50Iu5VT #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] @ZiadBakouny et al. @DrChoueiri @TMWiseDraper @COVID19nCCC @JAMAOnc jamanetwork.com/journals/jam... #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 @COVID19nCCC

COVID-19 vaccination and breakthrough infections in patients with cancer Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and possible risk of breakthrough infection. As clinical trials evaluating COVID-19 vaccines largely excluded patients with a history of cancer and those on active immunosuppression (including chemotherapy), limited evidence is available to inform the clinical efficacy of COVID-19 vaccination across the spectrum of patients with cancer.

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] @dr_aschmidt et al. @DrChoueiri @COVID19nCCC @Annals_Oncology ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] @dr_aschmidt et al. @DrChoueiri @COVID19nCCC @Annals_Oncology ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc

Crowdsourcing a crisis response for COVID-19 in oncology - Nature Cancer Crowdsourcing efforts are currently underway to collect and analyze data from patients with cancer who are affected by the COVID-19 pandemic. These community-led initiatives will fill key knowledge ga...

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC

twitter.com/DrMJoyner/st... #COVID19CP #CCC19 #COVID19nCancer cc @DrJPHenderson @hemoncwarner.bsky.social @equis @pgrivasmdphd.bsky.social

Frontiers | Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases Immunosuppressant conditions such as hematological malignancies increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ...

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Pts w/ Complete Remission B-Cell Lymphoma & Anti-CD20 mAb Therapy: A Case Report of 2 Cases [Apr 14, 2022] Martínez-Chinchilla et al. @FrontImmunol ow.ly/yOSa50IL3mn #COVID19nCancer #lymsm #IDonc #COVID19CP

502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer

Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer [Sep 13, 2022] @ZiadBakouny et al. @TMWiseDraper S772–S773 502P @Annals_Oncology www.ncbi.nlm.nih.gov/pmc/articles... @COVID19nCCC #COVID19nCancer #ImmunoOnc #IDonc

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data The urgent response to the COVID-19 pandemic has highlighted the importance of diverse, real-world data sources, such as electronic health records, insurance claims, and patient registries, to further...

Time-Related Biases in Nonrandomized COVID-19–Era Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc ow.ly/wTHl50FcSHZ #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role...

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

Real World Third COVID19 Vaccine Dosing & Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.org/jpcrr/vol9/i... #COVID19nCancer #COVID19Vaccine #IDonc

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer [Dec 10, 2021] @ArielleElkrief et al. @hemoncwarner @COVID19nCCC @CD_AACR ow.ly/2mkh50H8AUG #COVID19nCancer #CCC19

COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] @DrDimpyShah @Dr_Pankil_Shah @mtmdphd Transplant ID onlinelibrary.wiley.com/doi/10.1111/... #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study Patients with metastatic cancer have more severe outcomes than patients without metastasis, with those with metastasis to the brain having the highest odds of severe COVID-19. When adjusting for init....

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study [Feb 20, 2024] @ClCastellano et al. @JournalCancer
acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #CCC19 #COVID19nCancer #COVID19 @COVID19nCCC #camets

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen ow.ly/qvGM50Iu5VT #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19

Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (#CCC19) Study [Feb 14, 2022] Satyanarayana et al. @DFarmakiotis @COVID19nCCC Open Forum Infectious Diseases ow.ly/uHAz50HUZav #COVID19nCancer #IDonc #COVID19

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer

Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera @peters_solange et al @gary_lyman @hemoncwarner @CD_AACR ow.ly/e5Fl30qZTno #AACRCovid #COVID19nCancer n=2186

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc